
Quotient Sciences Recognized as a Winner of 2025 CDMO Leadership Awards
Read More136 - 140 of 153 results
An accomplished leader in the pharmaceutical industry with over 35 years’ experience, Claes Glassell has been appointed as non‐executive chairman of the Quotient Sciences board of directors. Glassell has held numerous leadership positions, ...
Learn moreQuotient Sciences and global investment firm Permira announced that a company backed by the Permira Funds has signed a definitive agreement to acquire a majority stake in Quotient Sciences.
Learn moreQuotient Sciences (“Quotient”), a leading drug development services and manufacturing organization, is pleased to announce that its Vice President of Pharmaceutical Sciences, Andy Lewis, has been appointed as Secretary of the Controlled Rel...
Learn moreQuotient Sciences announced that it has received a Transatlantic Growth Award at a ceremony hosted by BritishAmerican Business in London.
Learn morePaul Quigley shared his thoughts on the importance of flexibility, collaboration and innovation for the modern CDMO in Contract Pharma.
Learn more